Below are the most recent publications written about "Tobacco Use Disorder" by people in Profiles.
-
Lawand J, Ghali A, Dajani AH, Boufadel P, Bey H, Khan A, Abboud J. Nontobacco Nicotine Dependence and Rates of Periprosthetic Joint Infection and Other Postoperative Complications in Shoulder Arthroplasty: A Retrospective Analysis. J Am Acad Orthop Surg. 2025 Jan 15; 33(2):92-99.
-
Schnoll RA, Leone FT, Quinn MH, Stevens N, Flitter A, Wileyto P, Kimberly J, Beidas RS, Hatzell J, Siegel SD, Crawford G, Hill N, Deatley T, Ziedonis D. A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare. Drug Alcohol Depend. 2023 06 01; 247:109873.
-
Siegel SD, Laurenceau JP, Hill N, Bauer AM, Flitter A, Ziedonis D, Stevens N, Hosie Quinn M, Leone F, Beidas R, Kimberly J, Schnoll RA. Assessing barriers to providing tobacco use disorder treatment in community mental health settings with a revised version of the Smoking Knowledge, Attitudes, and Practices (S-KAP) instrument. Addict Behav. 2021 03; 114:106735.
-
Heffner JL, Kelly MM, Waxmonsky J, Mattocks K, Serfozo E, Bricker JB, Mull KE, Watson NL, Ostacher M. Pilot Randomized Controlled Trial of Web-Delivered Acceptance and Commitment Therapy Versus Smokefree.gov for Smokers With Bipolar Disorder. Nicotine Tob Res. 2020 08 24; 22(9):1543-1552.
-
Quintanilla ME, Ezquer F, Morales P, Santapau D, Berr?os-C?rcamo P, Ezquer M, Herrera-Marschitz M, Israel Y. Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options. Stem Cell Res Ther. 2019 07 08; 10(1):205.
-
Patterson F, Grandner MA, Malone SK, Rizzo A, Davey A, Edwards DG. Sleep as a Target for Optimized Response to Smoking Cessation Treatment. Nicotine Tob Res. 2019 01 04; 21(2):139-148.
-
Yiu Y, Tibbetts KM, Simpson CB, Matrka LA. Shar Pei Larynx: Supraglottic and Postcricoid Mucosal Redundancy and Its Association With Medical Comorbidities. Ann Otol Rhinol Laryngol. 2019 Feb; 128(2):121-127.
-
Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB. Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography. Biol Psychiatry. 2018 11 15; 84(10):715-721.
-
Kelly MM, Sido H, Rosenheck R. Rates and correlates of tobacco cessation service use nationally in the Veterans Health Administration. Psychol Serv. 2016 05; 13(2):183-92.
-
Gupta R, Verma V, Mathur P. Quitline Activity in Rajasthan, India. Asian Pac J Cancer Prev. 2016; 17(S2):19-24.